EuDial Working Group
European Dialysis Working Group
The EuDial Working Group is aimed at encouraging research, communicating knowledge, teaching and contributing to education in the field of haemodialysis. The acronym EuDial, standing for European Dialysis Working Group, has been chosen to best summarize its activity and mission: to improve outcomes of chronic kidney disease patients by enhancing the quality of dialysis therapies in their broader sense and facilitating collaborative research in this field.
Given the increasing scientific interest in convective therapies (hemodiafiltration and hemofiltration), the working group has decided to focus on convective renal replacement therapies as the first aim. The rationale of this first mission is supported by several facts that include increasing interest in convective therapies translating into the rapid growth of patients treated by modern versions of these therapies and several reports suggesting an improvement in CKD patient outcomes.
Join this working group
Being an ordinary member of the EuDial Working Group means being part of a network which facilitates exchanges of ideas on basic science research and new treatment protocols.
Becoming an ordinary member of the EuDial Working Group is free of charge and easy to do within your personal My ERA. Ordinary members must be ERA members and persons with a proven interest in the research area covered by the WG.
By joining the EuDial Working Group you will receive periodic newsletters with updates on the Working Group initiatives: e-seminars, CMEs, research projects and networking opportunities.
Towards a tailored prescription of dialysis adequacy: the key role of incremental hemodialysis
The conundrum of the complex relationship between acute kidney injury and cardiac arrhythmias
A call to optimize haemodialysis vascular access care in healthcare disrupted by COVID‑19 pandemic
At least 156 reasons to prioritize COVID-19 vaccination in patients receiving in-centre haemodialysis
Coronary Artery Disease in Dialysis Patients: Evidence Synthesis, Controversies and Proposed Management Strategies
Recommendations for the prevention, mitigation and containment of the emerging SARS-CoV-2 (COVID-19) pandemic in haemodialysis centres
Sudden cardiac death in dialysis patients: different causes and management strategies
Pros and cons of antithrombotic therapy in end-stage kidney disease: a 2019 update
Incremental haemodialysis and residual kidney function: more and more observations but no trials
Should a fistula first policy be revisited in elderly haemodialysis patients?
Home haemodialysis: how to build a program that works?
Sandip Mitra, United Kingdom
Natalie Borman, United Kingdom
Mehmet Kanbay, Turkey
Daljit Hothi, United Kingdom
The EuDial Board provides strategic direction to the working group. Board members enhance the exchange of expertise and international cooperation.
Christian Combe, France
Adrian Covic, Romania
Vassilios Liakopoulos, Greece
Valerie Luyckx, Switzerland
Rukshana Shroff, United Kingdom
Frank Van Der Sande, The Netherlands
Events organised by EuDial
EuDial CME Course 2018 “Haemodialysis Update 2018: from basics to advances in the treatment in CKD”
October 3, 2018, Rimini, Italy